Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TAG OIL LTD. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
TAG OIL LTD
TAG OIL LTD
GMP FirstEnergy ― UK Energy morning research package
17 Nov 16
Tag Oil (TAO CN); BUY, C$1.25: no major changes to estimates | Great Eastern Energy (GEEC LN) (not covered): Half Yearly Results ended 30 September 2016 | Santos (STO AU) (not covered): Farms into Papua New Guinea license | Premier Oil (PMO LN); SPEC. BUY; £1.20: 3Q16 Trading Update | DNO (DNO NO) (not covered): MoU in Iran | Orca Exploration (ORC.B CN): 3Q16 Results | Statoil (STL NO) (not covered): FID at Tanzania LNG delayed by five years
PROVIDES OPERATIONAL UPDATE
29 Sep 16
Market Impact: Neutral. TAG Oil is currently producing 1,200 boe/d, which is tracking very close to our fiscal 2Q17e (June to September 2016) production forecast of 1,226 boe/d and the Company's annual production guidance of 1,200 boe/d. TAG's waterflood project has commenced with water injection. A production response could take up to six to nine months.
Production Is Exceeding Expectations
01 Sep 16
At present, TAG's operations are performing above expectations. The Company's current production is approximately 1,400 boe/d, which is 17% greater than fiscal year 2017e (April 2016 to March 2017) production guidance of 1,200 boe/d and 14% greater than our fiscal 2Q17e (July 2016 to September 2016) production forecast of 1,226 boe/d. The production increase is predominantly due to new production at the Sidewinder Field of approximately 250 bbl/d. The new production at Sidewinder was from a recompletion exercise that will have a payback of approximately one month. There are also an additional two wells at Sidewinder that could potentially be brought on stream.
19 Jul 16
We are initiating coverage on TAG Oil with a target price of $1.25 per share and an Outperform ranking. TAG has a low risk, stable production profile that can be backstopped by a significant inventory of recompletion and development opportunities, which can be fully funded via cash flow from operations. There is an exploration portfolio that can be targeted in an improved crude oil price environment.A potentially significant catalyst for the Company is the upcoming waterflood project, which is currently not being valued but could result in reserve growth of approximately 25% and production growth of approximately 40%.
30 Nov 16
Abzena (ABZA): Interim results indicate happy customers (BUY) | Horizonte Minerals* (HZM): Fund raise completed (CORP) | SacOil* (SAC): Half-year trading statement (CORP) | Revolution Bars (RBG): New openings (BUY) | Amino Technologies* (AMO): Multi operator FUSION roll out (CORP)
Small Cap Breakfast
29 Nov 16
Asia Pacific Investment Partner - the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
24 Nov 16
Quixant* (QXT): Gaming gains (CORP) | SCISYS* (SSY): Bringing good news from Germany (CORP) | Hayward Tyler Group*: Contract wins (CORP) | Sound Energy (SOU): TE-7 flow rate and fund raise (BUY) | Water Intelligence* (WATR): Growth and improving returns in a defensive market (CORP) | Imaginatik* (IMTK): Interim trading update (CORP)
High grade, low cost gold
28 Nov 16
High grades and low costs mean that, in our view, Scotgold’s Cononish project could generate more than £14m a year in EBITDA. In addition to advancing funding discussions based on the compelling bankable feasibility study mine plan (which at £950/oz gold price and 8% WACC gives a project NPV of £43.0m), the company is exploring optimisation opportunities, as well as the potential for a phased approach requiring lower up front capital. We are resuming coverage with a Buy recommendation and target price of 2.2p